Clinical Trial Update: A Trial of Doxorubicin/Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D for Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial investigating alternating cycles of doxorubicin/cyclophosphamide and docetaxel for metastatic breast cancer; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Cyclophosphamide (Cytoxan) (cyclophosphamide)
• Docetaxel (Taxotere) (docetaxel)
• Doxorubicin (Adriamycin) (doxorubicin)

Snippet

Sponsor: Japan Clinical Oncology Group | Conditions: Breast Cancer, Neoplasm Metastasis | Phase 3 | Status: COMPLETED